These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 9798695)

  • 1. Serum cytokine levels after HLA-identical bone marrow transplantation.
    Liem LM; van Houwelingen HC; Goulmy E
    Transplantation; 1998 Oct; 66(7):863-71. PubMed ID: 9798695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical relevance of serum soluble interleukin-2 receptor levels in acute and chronic graft-versus-host disease.
    Kobayashi S; Imamura M; Hashino S; Tanaka J; Asaka M
    Leuk Lymphoma; 1997 Dec; 28(1-2):159-69. PubMed ID: 9498715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
    Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
    Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring soluble interleukin-2 receptor levels in related and unrelated donor allogenic bone marrow transplantation.
    Foley R; Couban S; Walker I; Greene K; Chen CS; Messner H; Gauldie J
    Bone Marrow Transplant; 1998 Apr; 21(8):769-73. PubMed ID: 9603399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble interleukin-6 receptors in hematology patients undergoing bone marrow transplantation.
    Toren A; Novick D; Or R; Ackerstein A; Slavin S; Nagler A
    Transplantation; 1996 Jul; 62(1):138-42. PubMed ID: 8693533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble interleukin-2 receptor levels in cytomegalovirus disease and graft versus host disease after T-lymphocyte depleted bone marrow transplantation for hematological neoplasias.
    Engelhard D; Nagler A; Singer R; Barak V
    Leuk Lymphoma; 1994 Jan; 12(3-4):273-80. PubMed ID: 8167558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of soluble interleukin-2 receptor after bone marrow transplantation: a true marker of acute graft-versus-host disease.
    Kami M; Matsumura T; Tanaka Y; Mikami Y; Miyakoshi S; Ueyama J; Morinaga S; Mori S; Machida U; Kanda Y; Chiba S; Sakamaki H; Hirai H; Muto Y
    Leuk Lymphoma; 2000 Aug; 38(5-6):533-40. PubMed ID: 10953974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of inflammatory cytokines in unrelated bone marrow transplantation.
    Nagler A; Bishara A; Brautbar C; Barak V
    Cytokines Cell Mol Ther; 1998 Sep; 4(3):161-7. PubMed ID: 9825841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous interleukin 1 receptor antagonist during human bone marrow transplantation: increased levels during graft-versus-host disease, during infectious complications, and after immunoglobulin therapy.
    Schwaighofer H; Oberhuber G; Hebart H; Einsele H; Herold M; Nachbaur D; Eibl B; Tilg H; Kropshofer G; Ferrara JL; Niederwieser D
    Transplantation; 1997 Jan; 63(1):52-6. PubMed ID: 9000660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased levels of soluble interleukin-2 receptor in veno-occlusive disease of the liver after allogenic bone marrow transplantation.
    Remberger M; Ringdén O
    Transplantation; 1995 Dec; 60(11):1293-9. PubMed ID: 8525524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell surface markers and circulating cytokines in graft versus host disease.
    Chang DM; Wang CJ; Kuo SY; Lai JH
    Immunol Invest; 1999 Jan; 28(1):77-86. PubMed ID: 10073684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-gamma, and tumor necrosis factor-alpha in graft-versus-host disease.
    Imamura M; Hashino S; Kobayashi H; Kubayashi S; Hirano S; Minagawa T; Tanaka J; Fujii Y; Kobayashi M; Kasai M
    Bone Marrow Transplant; 1994 Jun; 13(6):745-51. PubMed ID: 7920309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum concentration of the soluble interleukin-2 receptor for monitoring acute graft-versus-host disease.
    Miyamoto T; Akashi K; Hayashi S; Gondo H; Murakawa M; Tanimoto K; Harada M; Niho Y
    Bone Marrow Transplant; 1996 Feb; 17(2):185-90. PubMed ID: 8640164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble interleukin-2 receptor serum levels after allogeneic bone marrow transplantations as a marker for GVHD.
    Grimm J; Zeller W; Zander AR
    Bone Marrow Transplant; 1998 Jan; 21(1):29-32. PubMed ID: 9486491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serum HLA class I levels coincide with acute and chronic graft-versus-host disease.
    Liem LM; Koelman CA; Doxiadis II; van Houwelingen JC; Goulmy E; Claas FH
    Bone Marrow Transplant; 1997 Aug; 20(3):227-34. PubMed ID: 9257891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting graft-versus-host disease in HLA-identical bone marrow transplant: a comparison of T-cell frequency analysis and a human skin explant model.
    Dickinson AM; Sviland L; Wang XN; Jackson G; Taylor PR; Dunn A; Proctor SJ
    Transplantation; 1998 Oct; 66(7):857-63. PubMed ID: 9798694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease.
    Szebeni J; Wang MG; Pearson DA; Szot GL; Sykes M
    Transplantation; 1994 Dec; 58(12):1385-93. PubMed ID: 7809932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble interleukin-2 receptor level on day 7 as a predictor of graft-versus-host disease after HLA-haploidentical stem cell transplantation using reduced-intensity conditioning.
    Kaida K; Ikegame K; Ikemoto J; Murata R; Irie R; Yoshihara S; Ishii S; Okada M; Inoue T; Tamaki H; Soma T; Fujimori Y; Kai S; Ogawa H
    Int J Hematol; 2014 Apr; 99(4):463-70. PubMed ID: 24599414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.